HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, K.-H. Articles by Kim, B.-T. Search for Related Content PubMed PubMed Citation Articles by Lee, K.-H. Articles by Kim, B.-T.

Effects of Anesthetic Agents and Fasting Duration on ¹⁸F-FDG Biodistribution and Insulin Levels in Tumor-Bearing Mice

¹ Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
² Center for Molecular Imaging, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Small-animal PET has opened the way for imaging ¹⁸F-FDG uptake in murine tumor models, but the need for anesthesia raises concern over its potential influence on ¹⁸F-FDG kinetics. We thus investigated such effects on cultured cells and on tumor-bearing mice after short- and long-term fasting. Methods: Lewis lung carcinoma (LLC) cells and cardiomyoblasts were treated for 2 h with a 100 µmol/L concentration of xylazine, ketamine, xylazine plus ketamine (Xy/Ke), or pentobarbital and were measured for ¹⁸F-FDG uptake. LLC tumor–bearing C57BL6 mice that had been kept fasting for either 4 or 20 h were injected with Xy/Ke, pentobarbital, or saline and were administered 1.8 MBq of ¹⁸F-FDG 15 min later. Biodistribution studies and plasma glucose and insulin assays were performed 45 min after injection. Separate anesthetized and control mice underwent ¹⁸F-FDG PET. Results: ¹⁸F-FDG uptake in LLC cells was unaffected by anesthetic agents, whereas xylazine and ketamine caused a small increase of uptake in cardiomyoblasts. In mice kept fasting 4 h, Xy/Ke induced a marked elevation of ¹⁸F-FDG activity (percentage injected dose [%ID]) in blood (6.8 ± 0.9 %ID/g vs. 1.1 ± 0.6 %ID/g) and kidneys while decreasing myocardial uptake (2.3 ± 1.3 %ID/g vs. 4.7 ± 1.8 %ID/g). Target-to-blood ratios were significantly reduced. Pentobarbital caused a moderate increase in blood activity (2.5 ± 0.8 %ID/g), decreased myocardial uptake (2.8 ± 0.5 %ID/g), and reduced target-to-blood ratios. PET images of mice kept fasting 4 h were consistent with the biodistribution data. Insulin levels were lower with Xy/Ke and higher with pentobarbital. In mice kept fasting 20 h, Xy/Ke and pentobarbital increased blood ¹⁸F-FDG activity (5.5 ± 2.2 and 4.9 ± 0.9 %ID/g vs. 2.4 ± 0.3 %ID/g) and reduced target-to-blood ratios, but these changes were substantially attenuated, compared with those in mice kept fasting 4 h. In addition, insulin levels were low and unaffected by anesthesia. Conclusion: Xy/Ke anesthesia markedly elevates blood ¹⁸F-FDG activity and reduces tumor uptake ratios through inhibition of insulin release in mice kept fasting 4 h, whereas pentobarbital induces a similar but less severe response through insulin resistance. These metabolic effects, however, are substantially attenuated after 20 h of fasting. Hence both the choice of anesthetic and the duration of fasting have important effects on ¹⁸F-FDG kinetics and PET images of tumor-bearing mice and should be considered when such studies are performed.

Key Words: anesthesia • ¹⁸F-FDG, tumor • glucose • insulin

This article has been cited by other articles:

				F.-N. Roy, S. Beaulieu, L. Boucher, I. Bourdeau, and C. Cohade Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients J. Nucl. Med., February 1, 2009; 50(2): 178 - 183. [Abstract] [Full Text] [PDF]

				J. R. Tseng, K. W. Kang, M. Dandekar, S. Yaghoubi, J. H. Lee, J. G. Christensen, S. Muir, P. W. Vincent, N. R. Michaud, and S. S. Gambhir Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET J. Nucl. Med., January 1, 2008; 49(1): 129 - 134. [Abstract] [Full Text] [PDF]

				C. J. Zuurbier, P. J. M. Keijzers, A. Koeman, H. B. Van Wezel, and M. W. Hollmann Anesthesia's Effects on Plasma Glucose and Insulin and Cardiac Hexokinase at Similar Hemodynamics and Without Major Surgical Stress in Fed Rats Anesth. Analg., January 1, 2008; 106(1): 135 - 142. [Abstract] [Full Text] [PDF]

				M. Dandekar, J. R. Tseng, and S. S. Gambhir Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts J. Nucl. Med., April 1, 2007; 48(4): 602 - 607. [Abstract] [Full Text] [PDF]

				B. J. Fueger, J. Czernin, I. Hildebrandt, C. Tran, B. S. Halpern, D. Stout, M. E. Phelps, and W. A. Weber Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice J. Nucl. Med., June 1, 2006; 47(6): 999 - 1006. [Abstract] [Full Text] [PDF]